EP3.F OraSure Technologies Inc

Healthcare Health Care Equipment & Supplies Frankfurt Exchange
3.18 EUR
Close of Nov 11, 2026
1.80 4.00
Market cap
EUR 220M
P/E
-
P/B
0.75x
ROE
-12.7%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is EP3.F undervalued?

Graham number

The Graham number of OraSure Technologies Inc cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

OraSure Technologies Inc fundamental analysis

No fundamental analysis for OraSure Technologies Inc yet.

OraSure Technologies Inc stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About OraSure Technologies Inc

OraSure Technologies, Inc., together with its subsidiaries, develops, manufactures, markets, sells, and distributes diagnostic products and specimen collection devices in the United States, Europe, Africa, and internationally. It offers OraQuick Rapid HIV test, OraQuick HIV self-test, OraQuick HIV self-test(international), OraQuick HCV rapid antibody test and self-test, Syphilis health check rapid diagnostic test, OraQuick Ebola rapid antigen test, InteliSwab COVID-19 rapid …

Full company profile